L‑Lactate dehydrogenase B may be a predictive marker for sensitivity to anti‑EGFR monoclonal antibodies in colorectal cancer cell lines-Reference-Cited by-同舟云学术

L‑Lactate dehydrogenase B may be a predictive marker for sensitivity to anti‑EGFR monoclonal antibodies in colorectal cancer cell lines

Published:2019-02-26 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Nagamine Ayumu¹,Araki Takuya¹,Nagano Daisuke¹,Miyazaki Mitsue²,Yamamoto Koujirou¹

Affiliation:

1. Department of Clinical Pharmacology and Therapeutics, Gunma University Graduate School of Medicine, Maebashi, Gunma 371‑8511, Japan

2. Division of Endocrinology Metabolism and Signal Research, Gunma University Initiative for Advanced Research and Institute for Molecular and Cellular Regulation, Maebashi, Gunma 371‑8511, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining structure-based and 3D QSAR pharmacophore models to discover diverse ligands against EGFR in oral cancer;Future Medicinal Chemistry;2022-04

2. Altered glycolysis results in drug‑resistant in clinical tumor therapy (Review);Oncology Letters;2021-03-11

3. Revisiting lactate dynamics in cancer—a metabolic expertise or an alternative attempt to survive?;Journal of Molecular Medicine;2020-08-22

4. The usefulness of lactate dehydrogenase measurements in current oncological practice;Cellular & Molecular Biology Letters;2020-06-09

5. Targeting Cancer Metabolism to Resensitize Chemotherapy: Potential Development of Cancer Chemosensitizers from Traditional Chinese Medicines;Cancers;2020-02-10